NCT04610957View on ClinicalTrials.gov

Effect of Adding Isoflavonoids to Clomiphene Citrate for Ovulation Induction in Women With Polycystic Ovary Syndrome

NACompletedINTERVENTIONAL

Enrollment

160

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

January 1, 2019

Study Completion Date

April 10, 2019

Conditions

Ovulation InductionPolycystic Ovary Syndrome

Interventions

DRUG

Rosafem (FEMININE FORMULA)

Rosafem is the only phytoestrogen product with the convenient dose which provides significant improvement of menopausal related symptoms premenstrual syndrome symptoms

Trial Locations (1)

23451

Faculty of Medicine, Zagazig

All Listed Sponsors

lead

FAlbasri

OTHER_GOV

NCT04610957 - Effect of Adding Isoflavonoids to Clomiphene Citrate for Ovulation Induction in Women With Polycystic Ovary Syndrome | Biotech Hunter | Biotech Hunter